Submit Deal

Submit Deal

Cover Image Art Krieg

Art Krieg

Founder and Chief Scientific Officer at CHECKMATE PHARMACEUTICALS

Manager

Deal Bio

Total Deals1

Valued Deals1

Total Value£ 192 M

Avg. Deal Size£ 192 M

Market Context

Sort

19 Apr 2022|United States|Biotechnology

Target: CHECKMATE PHARMACEUTICALS

Bidder: REGENERON

7 Service Providers

5 Target | 2 Bidder

62 Dealmakers

48 Target | 14 Bidder

£ 191 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Art Krieg